RDY
Dr. Reddy’s Laboratories Ltd ADR
NYSE: RDY · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$13.73
-2.14% today
Updated 2026-04-29
Market cap
$11.46B
P/E ratio
19.07
P/S ratio
0.03x
EPS (TTM)
$0.72
Dividend yield
0.67%
52W range
$13 – $16
Volume
2.4M
Dr. Reddy’s Laboratories Ltd ADR (RDY) Financial statements
SEC filings — annual and quarterly data.
Profit margin
16.40%
Operating margin
16.40%
ROE
16.10%
ROA
7.96%
Debt/equity
0.18x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $24.33B | $1.63B | 48.83% | 5.94% | 6.71% |
| 2007 | $65.25B | $9.35B | 47.43% | 17.24% | 14.33% |
| 2008 | $50.01B | $4.68B | 50.81% | 6.71% | 9.36% |
| 2009 | $69.44B | $-5.17B | 52.56% | -4.08% | -7.44% |
| 2010 | $70.28B | $1.07B | 51.71% | 2.86% | 1.52% |
| 2011 | $74.69B | $11.04B | 53.90% | 16.91% | 14.78% |
| 2012 | $96.74B | $14.26B | 55.10% | 18.87% | 14.74% |
| 2013 | $116.27B | $16.78B | 52.10% | 18.16% | 14.43% |
| 2014 | $132.17B | $21.51B | 57.35% | 19.70% | 16.28% |
| 2015 | $148.19B | $22.18B | 57.63% | 17.74% | 14.97% |
| 2016 | $154.71B | $20.01B | 59.65% | 19.15% | 12.94% |
| 2017 | $140.81B | $12.04B | 55.65% | 9.59% | 8.55% |
| 2018 | $142.03B | $9.81B | 53.72% | 8.39% | 6.90% |
| 2019 | $153.85B | $18.80B | 54.23% | 13.58% | 12.22% |
| 2020 | $174.60B | $19.50B | 53.84% | 9.16% | 11.17% |
| 2021 | $2.56B | $232.21M | 50.78% | 16.88% | 9.09% |
| 2022 | $214.39B | $23.57B | 53.10% | 13.75% | 10.99% |
| 2023 | $245.88B | $45.07B | 56.67% | 23.24% | 18.33% |
| 2024 | $279.16B | $55.68B | 58.61% | 24.26% | 19.95% |
| 2025 | $325.54B | $56.54B | 58.50% | 22.07% | 17.37% |